RE: RNS20 Jul 2023 11:47
As an ex LTH, I would say that a recurring theme with GCAT has been for it to promise one thing, but then deliver something else. Last year it was 24koz by year end, and non-dilutive finance. Ended up delivering significant dilutive finance, which they didn't even bother revealing to the market, and requiring emergency funding to keep the lights on. There was also lots of selling going on in the background throughout most of the year.
This year's yarn is the discovery of a new high grade gold zone and looking once again to secure financing for that 24Koz expansion, supposedly with lots of interest from potential financiers. Instead of doing as many interviews, it seems that the approach is to rely more on twitter comms.
What has been delivered so far? Has anything materially changed? Is it another year of smoke and mirrors, or is this going to be year that they actually do deliver what they say they are working towards?
It's a question of whether you trust the company and its BOD (what's left of it anyway) to do that? If you do 100%, then you will be happy to hold/buy, and be enthused by the tweets. If you don't have that 100% trust, then you will either want to wait for official and confirmatory information in RNS, Quarterlies and the Prospectus, or not wish to touch this at all.
Where you are on this trust scale, and your attitude to risk etc, will then determine how you feel about GCAT overall.
I'm in the 'once (almost) bitten, twice shy' camp, so will wait for and only act on RNS, and not what is said in interviews and/or twitter. But I respect the fact that others feel differently.
I've lost count of the number of time this has been said about GCAT, but the next 3 months will reveal whether it's another year of overpromise and under delivery (aka smoke and mirrors), or finally putting the company on a proper financial footing to then deliver on its 24Koz at Kili, continue its exploration at VR and TZ, and achieve its promises. All imo and dyor